Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
L. Smith, J.L. Reynolds.
Factors associated with the decision of family physicians to provide intrapartum care.
CMAJ, 152 (1995), pp. 1789-1797
[2.]
A. Hakansson.
Comparación entre los resultados del cuidado prenatal efectuado por el médico de medicina general y los obtenidoscuando es realizado por el obstetra.
Acta Obstet Gynecol Scand (ed esp.), 2 (1989), pp. 557-562
[3.]
L. Hingstman.
Primary care obstetrics and perinatal health in the Netherlands.
J Nurse Midwifery, 39 (1994), pp. 379-386
[4.]
M. Bull.
GP obstetrics: making the most of shared care.
Practitioner, 22 (1989), pp. 211-215
[5.]
L. Baldwin, T. Raine, L. Jenkins, G. Hart, R. Rosenblatt.
Do provides adhere to ACOGS stand? The case of prenatal care.
Obstet Gynecol, 84 (1994), pp. 549-555
[6.]
J.E. Scherger, C. Levitt, L.S. Acheson, T. Nesbitt, C. Johnson, K. Reilly, et al.
Teaching family-centered perinatal care in Family Medicine, Parts 1 and 2.
Fam Med, 24 (1992), pp. 288-298
[7.]
M.B. Mengel, W.R. Phillips.
The quality of obstetric care in family practice: are family physicians as safe as obstetricians?.
J Fam Pract, 24 (1987), pp. 159-164
[8.]
S. Zweig, J. Kruse, M. LeFevre.
Patient satisfaction with obstetric care.
J Fam Pract, 23 (1986), pp. 131-136
[9.]
J. Villar, D. Khan-Neelofur.
Patterns of routine antenatal care for low-risk pregnancy (Cochrane Review). En: The Cochrane Library, Issue 2.
[10.]
J.S. Tucker, M.H. Hall, P.W. Howie, M.E. Reid, R.S. Barbour, C. Florey, G.M. McIlwaine.
Should obstetricians see women with normal pregnancies? A Multicentre randomised controlled trial of routine antenatal care by general practitioners and midwives compared with shared care led by obstetricians.
BMJ, 312 (1996), pp. 554-559
[11.]
R. Castejón, A. Delgado, L. Revilla, J.M. Solís, F. Ceinos, J.A. Bellón.
Estudio comparativo de la calidad de atención prenatal entre centros de salud y hospital.
Aten Primaria, 9 (1992), pp. 85-88
[12.]
Manual de Atención al Embarazo, Parto y Puerperio.
Sevilla: Consejería de Salud y Consumo.
Junta de Andalucía, (1994),
[13.]
E. Bailón.
La pareja que espera.
Manual de Atención Familiar II, pp. 607-632
[14.]
L. Revilla.
El genograma: cómo interpretarlo.
Conceptos e instrumentos de la atención familiar, pp. 111-123
[15.]
L. Revilla.
La atención longitudinal: el ciclo vital familiar.
Conceptos e intrumentos de la atención familiar, pp. 37-42
[16.]
M.D. Pagel, D. Montano, H. Regen, G. Smilkstein.
Influences on new born outcomes: a controlled prospective study.
Soc Sci Med, 30 (1990), pp. 597-604
[17.]
L. Revilla, E. Bailón.
Recursos familiares.
Conceptos e instrumentos de la atención familiar, pp. 79-90
[18.]
L. Revilla, E. Bailón, J.D. Luna, A. Delgado, M.A. Prados, L. Fleitas.
Validación de una escala de apoyo social funcional para uso en la consulta del médico de familia.
Aten Primaria, 8 (1991), pp. 688-691
[19.]
C.D. Sherbourne, A. Stewart.
The MOS social support survey.
Soc Sci Med, 32 (1991), pp. 705-714
[20.]
B. Jack, L. Culpepper.
Preconception care: risk, reduction and health promotion in preparation for pregnancy.
JAMA, 264 (1990), pp. 1147-1149
[21.]
Estudio Colaborativo Español de Malformaciones Congénitas (ECEMC).
Utilización periconcepcional de ácido fólico y prevención de defectos del tubo neural. Informe técnico.
[22.]
Medical Research Council (MCR) Vitamin Study Research Group.
Prevention of neural tube defects: Results of Medical Research Council Vitamin Study.
Lancet, 338 (1991), pp. 131-137
[23.]
A.E. Czeicel, I. Dudas.
Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation.
N Engl J Med, 327 (1992), pp. 1832-1835
[24.]
A. Milunsky, S.S. Jick, et al.
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects.
JAMA, 262 (1989), pp. 2847-2852
[25.]
M.K. Menard.
Complementos de vitaminas y minerales antes y durante el embarazo. En: Clínicas de ginecología y obstetricia. Temas actuales.
Méjico: McGraw-Hill Interamericana,, 3 (1997), pp. 433-450
[26.]
Center for Disease Control.
Use of folic acid for prevention of spina bifida and other neural tube defects 1983-1991.
MMWR, 40 (1991), pp. 513-516
[27.]
R.J. Berry, Z. Li, D. Erickson, S. Li, C. Moore, H. Wang, et al.
Prevention of neural-tube defects with folic acid in China.
N Engl J Med, 341 (1999), pp. 1485-1490
[28.]
Canadian Task Force on the Periodic Health Examination Canada Guide to clinical preventive health care.
pp. 74-81
[29.]
US Preventive Services Task Force.
Cribado de los defectos del tubo neural, incluyendo profilaxis con ácido fólico. En: Guía de medicina clínica preventiva.
Barcelona: Medical Trends,, (1998), pp. 361-373
[30.]
American College of Obstetrician s and Gynecologists.
Seizure disorders in pregnancy.
ACOG Educ Bull, 231 (1996),
[31.]
S. Kaneko, D. Battino, E. Andermann, K. Wada, R. Kan, A. Takeda, et al.
Congenital malformations due to antiepileptic drugs.
Epilepsy Res, 33 (1999), pp. 145-158
[32.]
N.R. Campbell, B.B. Hasinoff.
Iron supplements: a common cause of drug interactions.
Br J Clin Pharmac, 31 (1991), pp. 251-255
[34.]
M. Enkin, M.J. Keirse, M. Renfrew, J. Neilson.
A guide to effective care in pregnancy and childbirth.
pp. 126-134
[35.]
The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI).
National Institutes of Health, (1997),
[36.]
Directrices de la Organización Mundial de la Salud y de la Sociedad Internacional de Hipertensión para el Tratamiento de la Hipertensión, 1999.
Subcomité de directrices.
Iberoam J Hypertens, 17 (1999), pp. 26-27
[37.]
C.D. Chambers, K.A. Johnson, R.J. Felix, L.M. Dick, K.L. Jones.
Hyperthermia in pregnancy: a prospective cohort study.
Teratology, 55 (1997), pp. 45
[38.]
M.J. Edwards, K. Shiota, M.S. Smith, D.A. Walsh.
Hyperthermia and birth defects.
Reprod Toxicol, 9 (1995), pp. 411-425
[39.]
A. Lipson, W. Webster, M. Edwards.
Sauna and birth defects.
Teratology, 32 (1985), pp. 147-148
[40.]
P.M. Layde, L.D. Edmonds, J.D. Erickson.
Maternal fever and neural tube defects.
Teratology, 21 (1980), pp. 105-108
[41.]
A. Milunsky, M. Ulcickas, K.J. Rothman, W. Willett, S.S. Jick, H. Jick.
Maternal heat exposure and neural tube defects.
JAMA, 268 (1992), pp. 882-885
[42.]
J.M. Graham, J.E. Matthew, J.E. Marshall.
Teratogen update: gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humans.
Teratology, 58 (1998), pp. 209-221
[43.]
A.D. McDonald, B.G. Armstrong, M. Sloan.
Cigarette, alcohol and coffee consumption and prematurity.
Am J Public Health, 82 (1992), pp. 87-90
[44.]
J. Kleinman, M. Pierre, J. Madans, et al.
The effects of maternal smoking on fetal and infant mortality.
Am J Epidemiology, 127 (1988), pp. 274-282
[45.]
C.D. Coles.
Impact of prenatal alcohol exposure on the newborn and the child.
Clin Obstet Gynecol, 36 (1993), pp. 255-266
[46.]
F. Bolumar, L. Ferrer, M. Rebagliato, S. Pérez Hoyos, A. Pérez Aytes, J. Monleón.
Efecto del consumo moderado de alcohol durante el embarazo sobre el peso del recién nacido.
Med Clin (Barc), 102 (1994), pp. 765-768
[47.]
Cafeína durante el embarazo: ¿motivos para preocuparse? [editorial].
JAMA (ed. esp), 3 (1994), pp. 319-321
[48.]
C. Maroto.
Mecanismo de transmisión vertical en las infecciones perinatales. Libro Ponencias XII Congreso de la Sociedad Andaluza de Ginecología y Obstetricia.
Aguadulce (Almería), (1999), pp. 19-20
[49.]
J.M. Aranda, J.D. Luna.
Aplicación de la estrategia de riesgo para la transformación de los servicios de salud materno-infantil en Andalucía.
[50.]
M.D. Pagel, D. Montano, H. Regen, G. Smilkstein.
Psychosocial influences on new born outcomes: a controlled prospective study.
Soc Sci Med, 30 (1990), pp. 597-604
[51.]
H. Gibblint.
Social Support effects on health behavior and antenatal care.
J Community Health, (1990),
[52.]
Factores de riesgo SEGO
[53.]
N.J. Wald, H.C. Watt, A.K. Hackshaw.
Integrated screening for Down's syndrome based on test performed during the first and second trimesters.
N Engl J Med, 341 (1999), pp. 461-467
[54.]
J.A. Copel, R.O. Badaho-Singh.
Prenatal screening for Down's syndrome. A search for de family's values.
N Engl J Med, 341 (1999), pp. 521-522
[55.]
D.A. Luthy.
Maternal markers and complications of pregnancy.
N Engl J Med, 341 (1999), pp. 2085-2087
[56.]
I. Fernández, M. Lubián, et al.
Situaciones especiales: diabetes y embarazo. En: Diabetes mellitus en medicina familiar.
Sociedad Andaluza de Medicina Familiar y Comunitaria, (1997),
[57.]
Grupo de trabajo de vacunación en el adulto.
Sociedad Española de Medicina Preventiva, Salud Pública e Higiene.
Guía de vacunación en el adulto, (1995),
[58.]
P. Smerdly.
Topical Iodine-containing antiseptics and neonatal hypothyroidism in very-low-birthweight infants.
Lancet, 2 (1989), pp. 661-664
[59.]
P.C. Clemens.
The Wolff-Chaikoff effect: hypothyroidism due to iodine application.
Arch Dermatol, 125 (1989), pp. 705
[60.]
N.M. Newman.
Use of povidone-iodine in umbilical cord care (carta).
Clin Ped, 28 (1989), pp. 37
[61.]
J. Arena.
Yatrogenia por iodo en el recién nacido: repercusión sobre la detección neonatal del hipotiroidismo. En: Diez años de programa de detección precoz de enfermedades endocrino-metabólicas en la Comunidad Autónoma Vasca.
pp. 75-84
[62.]
R. Feldman, et al.
Vaginal clorhexidine disinfection during labour (carta).
Lancet, (1992), pp. 791-792
[63.]
A. Sainz.
Povidona iodada al 10% versus clorhexidina 0,5% en el control de la infección de la episiotomía.
Farm Clin, 7 (1990), pp. 525-527
Copyright © 2000. Elsevier España, S.L. y Sociedad Española de Medicina Rural y Generalista (SEMERGEN)
